Market Access News | pharmaphorum

News

AZ may get government aid for UK vaccines facility; report

The UK government is reportedly considering a financial aid package to encourage AstraZeneca to invest in an expansion of its vaccines manufacturing facility in Speke, nea

News

DiMe project will develop recipe for digital health success

A consortium led by the Digital Medicine Society (DiMe) has been formed to tackle a thorny problem for digital health product (DHP) developers – how to bring them to marke

News

Dr Kurdow Nader, Consultant Neuroradiologist at University Hospitals Birmingham

NICE backs two AIs for stroke diagnosis in NHS

Two artificial intelligence-powered software tools – e-Stroke and RapidAI – have been recommended for use in the NHS to help detect stroke from CT brain scans by NICE.

News

AZ bags first approval for PNH therapy danicopan, in Japan

AstraZeneca has claimed its first regulatory approval for oral Factor D inhibitor danicopan, getting a green light in Japan for the drug as Voydeya for the treatment of pa

News

FDA turns down Satsuma’s nasal migraine treatment

Manufacturing problems have scuppered Satsuma Pharmaceuticals’ chances of a timely FDA approval for its intranasal migraine therapy STS101.

News

NICE backs Pfizer’s Talzenna for advanced breast cancer

Pfizer’s PARP inhibitor Talzenna has become the first targeted treatment for HER2-negative locally advanced or metastatic breast cancer with BRCA1/2 mutations to be recomm

AZ may get government aid for UK vaccines facility; report

DiMe project will develop recipe for digital health success

NICE backs two AIs for stroke diagnosis in NHS

AZ bags first approval for PNH therapy danicopan, in Japan

FDA turns down Satsuma’s nasal migraine treatment

NICE backs Pfizer’s Talzenna for advanced breast cancer

FDA orders blindness risk warning to GLP-1 agonist labels

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks